Longitudinal Trajectories of Memory Performance in Patients with Early-Stage Breast Cancer
| Autor: | Alexandra C. Apple, Cutter A. Lindbergh, Susan M. Landau, Amy DeLuca, Jamie L. Eberling, William J. Jagust, Joel H. Kramer, Hope S. Rugo, Lara H. Heflin |
|---|---|
| Přispěvatelé: | Zhao, Dan |
| Rok vydání: | 2022 |
| Předmět: |
Aging
Article Subject Clinical Sciences Oncology and Carcinogenesis Neurosciences Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) Evaluation of treatments and therapeutic interventions Neurodegenerative Alzheimer's Disease Basic Behavioral and Social Science Brain Disorders Oncology Clinical Research Medical Microbiology 6.1 Pharmaceuticals Behavioral and Social Science Breast Cancer Acquired Cognitive Impairment Dementia Mental health Cancer |
| Popis: | Background. While breast cancer and its treatments may affect cognition, the longitudinal trajectories of cognition among those receiving differing cancer treatment types remain poorly understood. Prior research suggests hippocampal-prefrontal cortex network integrity may influence cognition, although how this network predicts performance over time remains unclear. Methods. We conducted a prospective trial including 69 patients with early-stage breast cancer receiving adjuvant therapy and 12 controls. Longitudinal cognitive testing was conducted at four visits: pretreatment-baseline, 6-7 months, 14-15 months, and 23-24 months. Cognitive composite scores of episodic memory, executive functioning, and processing speed were assessed at each timepoint. Baseline structural MRI was obtained in a subset of these participants, and hippocampal and prefrontal cortex regional volumes were extracted. Results. Longitudinal linear mixed modeling revealed significant group by time interactions on memory performance, controlling for age and education. Post hoc analyses revealed this effect was driven by patients treated with chemotherapy or chemotherapy plus hormone therapy, who demonstrated the least improvement in memory scores over time. Treatment group did not significantly influence the relationship between time and processing speed or executive functioning. Neither pretreatment hippocampal nor prefrontal volume differed between groups, and there were no significant group by time by baseline regional volume effects on cognition. Conclusion. Patients with early-stage breast cancer treated with chemotherapy or chemotherapy plus hormone therapy benefit less from practice effects seen in healthy controls on memory tests. Loss of longitudinal practice effect may be a new and clinically relevant measure for capturing patients’ experience of cognitive difficulties after treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|